Drug
ZL 1218
ZL 1218: highest development phase Phase 1, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-1218 NCT05859464 | Phase 1 | Malignant Solid Tumor |
Latest
No recent events.
Follow ZL 1218 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.